Diseases

Whitehead Institute Founding Member Harvey Lodish was co-recipient of the 2021 MITx Prize for Teaching and Learning in MOOCs, and Whitehead Institute Member Sebastian Lourido has been named as one of the Burroughs Wellcome Fund’s 2021 Investigators in the Pathogenesis of Infectious Disease. 

A paper from the lab of Whitehead Institute Member Rudolf Jaenisch suggests that the genetic material of SARS-CoV-2 can integrate into the host cell genome and be expressed in some patient-derived tissues.

Researchers in the lab of Whitehead Institute Founding Member Robert Weinberg have determined how mesenchymal cancer cells may resist treatment, work that may allow them to make once-resistant tumors respond to certain cancer therapies.

Founding Member Harvey Lodish has been twice honored by the international science community for his path-breaking scientific accomplishments and intellectual leadership.

Tobiloba Oni—a cell biologist whose graduate research at Cold Spring Harbor Laboratory helped open new paths for understanding, detecting, and potential treating pancreatic cancer—has been appointed as a Whitehead Fellow.

In this episode of AudioHelicase Podcast, Whitehead Fellow Silvi Rouskin discusses her research on solving the structure of the novel coronavirus's RNA genome, with the goal of revealing weak points in the virus’s gene regulation that new drugs could potentially target.

A new experimental system shows how insulin-producing beta cells react under autoimmune attack during type 1 diabetes; the results could lead to better treatments.

A new MIT course on the COVID-19 pandemic, available to the public online, brings together top COVID-19 experts to educate students on up-to-date pandemic science.